Search

Your search keyword '"Service de Dermatologie"' showing total 2,085 results
Start Over Author "Service de Dermatologie" Search Limiters Available in Library Collection
2,085 results on '"Service de Dermatologie"'

1. Epithelioid Fibrous Histiocytoma with CARS-ALK Fusion: First Case Report

Author

UCL - (SLuc) Service d'anatomie pathologique, UCL - SSS/IREC - Institut de recherche expérimentale et clinique, UCL - (SLuc) Service de dermatologie, UCL - (SLuc) Centre de génétique médicale UCL, Secco, Léo-Paul, Libbrecht, Louis, Seijnhaeve, Elsa, Eggers, Silke, Dekairelle, Anne-France, De Roo, An-Katrien, UCL - (SLuc) Service d'anatomie pathologique, UCL - SSS/IREC - Institut de recherche expérimentale et clinique, UCL - (SLuc) Service de dermatologie, UCL - (SLuc) Centre de génétique médicale UCL, Secco, Léo-Paul, Libbrecht, Louis, Seijnhaeve, Elsa, Eggers, Silke, Dekairelle, Anne-France, and De Roo, An-Katrien

Abstract

Epithelioid fibrous histiocytoma (EFH) is a type of uncommon skin tumor mostly harboring Anaplastic Lymphoma Kinase (ALK) gene rearrangement, with different fusion partners reported. Whether this tumor is a separate entity or has a relationship with conventional fibrous histiocytomas is still a matter of debate. Benign course is the rule after complete surgical excision. A rare subtype of EFH with fusiform cells has been described, with specific fusion partners. Inflammatory myofibroblastic tumor (IMT) is a type of soft tissue tumor rarer than EFH, and it can display distant metastases. Some cases of primary cutaneous IMT included two with Cysteinyl-tRNA Synthetase 1 (CARS)-ALK rearrangement. IMT can have the same fusion partners as EFH, such as DCTN1, TMP3 or EML4 genes. We report the case of a 42-year-old woman presenting EFH with fusiform morphology harboring CARS-ALK fusion and discuss similarities and differences with IMT.

Published
2023

2. Dermatoscopic and clinical features of congenital or congenital-type nail matrix nevi: A multicenter prospective cohort study by the International Dermoscopy Society.

Author

UCL - SSS/IRSS - Institut de recherche santé et société, UCL - (SLuc) Service de dermatologie, Pham, Félix, Boespflug, Amélie, Duru, Gérard, Phan, Alice, Poulalhon, Nicolas, Weiler, Laura, Tanaka, Masaru, Lallas, Aimilios, Ogata, Dai, Davaine, Anne Céline, Bahadoran, Philippe, Balguerie, Xavier, Kamińska-Winciorek, Grażyna, Tromme, Isabelle, Correia, Osvaldo, Kim, Moon-Bum, Marghoob, Ashfaq A, Linda Martin, Guitera, Pascale, Meziane, Mariame, Miquel, Juliette, Mun, Je-Ho, Argenziano, Giuseppe, Bessis, Didier, Bourke, Johnny, Mijuskovic, Zeljko, Chiaverini, Christine, Corven-Benoit, Cloé, Droitcourt, Catherine, Skowron, François, Marque, Myriam, Zalaudek, Iris, Rosendahl, Cliff, Moreno-Ramirez, David, Vabres, Pierre, Haenssle, Holger, Malvehy, Josep, Puig, Susana, Robert, Caroline, Schopf, Thomas R, Scope, Alon, Dalle, Stéphane, Thomas, Luc, UCL - SSS/IRSS - Institut de recherche santé et société, UCL - (SLuc) Service de dermatologie, Pham, Félix, Boespflug, Amélie, Duru, Gérard, Phan, Alice, Poulalhon, Nicolas, Weiler, Laura, Tanaka, Masaru, Lallas, Aimilios, Ogata, Dai, Davaine, Anne Céline, Bahadoran, Philippe, Balguerie, Xavier, Kamińska-Winciorek, Grażyna, Tromme, Isabelle, Correia, Osvaldo, Kim, Moon-Bum, Marghoob, Ashfaq A, Linda Martin, Guitera, Pascale, Meziane, Mariame, Miquel, Juliette, Mun, Je-Ho, Argenziano, Giuseppe, Bessis, Didier, Bourke, Johnny, Mijuskovic, Zeljko, Chiaverini, Christine, Corven-Benoit, Cloé, Droitcourt, Catherine, Skowron, François, Marque, Myriam, Zalaudek, Iris, Rosendahl, Cliff, Moreno-Ramirez, David, Vabres, Pierre, Haenssle, Holger, Malvehy, Josep, Puig, Susana, Robert, Caroline, Schopf, Thomas R, Scope, Alon, Dalle, Stéphane, and Thomas, Luc

Abstract

BACKGROUND: Congenital nail matrix nevi (NMN) are difficult to diagnose because they feature clinical characteristics suggestive of adult subungual melanoma. Nail matrix biopsy is difficult to perform, especially in children. OBJECTIVE: To describe the initial clinical and dermatoscopic features of NMN appearing at birth (congenital) or after birth but before the age of 5 years (congenital-type). METHODS: We conducted a prospective, international, and consecutive data collection in 102 hospitals or private medical offices across 30 countries from 2009 to 2019. RESULTS: There were 69 congenital and 161 congenital-type NMNs. Congenital and congenital-type NMN predominantly displayed an irregular pattern of longitudinal microlines (n = 146, 64%), reminiscent of subungual melanoma in adults. The distal fibrillar ("brush-like") pattern, present in 63 patients (27.8%), was more frequently encountered in congenital NMN than in congenital-type NMN (P = .012). Moreover, congenital NMN more frequently displayed a periungual pigmentation (P = .029) and Hutchinson's sign (P = .027) than did congenital-type NMN. LIMITATIONS: Lack of systematic biopsy-proven diagnosis and heterogeneity of clinical and dermatoscopic photographs. CONCLUSION: Congenital and congenital-type NMN showed worrisome clinical and dermatoscopic features similar to those observed in adulthood subungual melanoma. The distal fibrillar ("brush-like") pattern is a suggestive feature of congenital and congenital-type NMN.

Published
2022

3. Immunological aspects of chronic spontaneous urticaria

Author

UCL - SSS/IREC/PNEU - Pôle de Pneumologie, ORL et Dermatologie, UCL - (SLuc) Service de dermatologie, de Montjoye, Laurence, UCL - SSS/IREC/PNEU - Pôle de Pneumologie, ORL et Dermatologie, UCL - (SLuc) Service de dermatologie, and de Montjoye, Laurence

Published
2022

6. Dermoscopie : take-home messages

Author

UCL - (SLuc) Service de dermatologie, Degraeuwe, Alexia, UCL - (SLuc) Service de dermatologie, and Degraeuwe, Alexia

Published
2022

7. Atopische dermatitis, een overzichtelijke opfrissing van de basisprincipes

Author

UCL - SSS/IREC/PNEU - Pôle de Pneumologie, ORL et Dermatologie, UCL - (SLuc) Service de dermatologie, Terrasson, Julie, Baeck, Marie, Gutermuth, Jan, UCL - SSS/IREC/PNEU - Pôle de Pneumologie, ORL et Dermatologie, UCL - (SLuc) Service de dermatologie, Terrasson, Julie, Baeck, Marie, and Gutermuth, Jan

Published
2022

10. Dermatite atopique, un rappel clair des principes de base

Author

UCL - SSS/IREC - Institut de recherche expérimentale et clinique, UCL - (SLuc) Service de dermatologie, Terrasson, Julie, Baeck, Marie, Gutermuth, Jan, UCL - SSS/IREC - Institut de recherche expérimentale et clinique, UCL - (SLuc) Service de dermatologie, Terrasson, Julie, Baeck, Marie, and Gutermuth, Jan

Published
2022

11. Eosinophilic cellulitis after BNT162b2 mRNA Covid-19 vaccine.

Author

UCL - (SLuc) Service de dermatologie, UCL - (SLuc) Service d'anatomie pathologique, UCL - SSS/IREC/PNEU - Pôle de Pneumologie, ORL et Dermatologie, UCL - (SLuc) Centre de l'allergie, de Montjoye, L, Marot, L, Baeck, M, UCL - (SLuc) Service de dermatologie, UCL - (SLuc) Service d'anatomie pathologique, UCL - SSS/IREC/PNEU - Pôle de Pneumologie, ORL et Dermatologie, UCL - (SLuc) Centre de l'allergie, de Montjoye, L, Marot, L, and Baeck, M

Abstract

No abstract available

Published
2022

12. Acute haemorrhagic oedema-like eruption in an adult.

Author

UCL - (SLuc) Service de dermatologie, UCL - (SLuc) Service d'anatomie pathologique, UCL - SSS/IREC/PNEU - Pôle de Pneumologie, ORL et Dermatologie, UCL - (SLuc) Centre de malformations vasculaires congénitales, UCL - (SLuc) Centre de l'allergie, De Greef, A, Dachelet, C, Marot, L, Baeck, M, UCL - (SLuc) Service de dermatologie, UCL - (SLuc) Service d'anatomie pathologique, UCL - SSS/IREC/PNEU - Pôle de Pneumologie, ORL et Dermatologie, UCL - (SLuc) Centre de malformations vasculaires congénitales, UCL - (SLuc) Centre de l'allergie, De Greef, A, Dachelet, C, Marot, L, and Baeck, M

Abstract

No abstract available

Published
2022

13. Pandemic chilblains: Are they SARS-CoV-2-related or not?

Author

UCL - (SLuc) Service de dermatologie, UCL - SSS/DDUV/GECE - Génétique cellulaire, De Greef, Axel, Coulie, Pierre G., Baeck, Marie, UCL - (SLuc) Service de dermatologie, UCL - SSS/DDUV/GECE - Génétique cellulaire, De Greef, Axel, Coulie, Pierre G., and Baeck, Marie

Abstract

The exact etiopathology of chilblains observed during the Coronavirus Disease 2019 (COVID-19) pandemic is still unclear. Initially, SARS-CoV-2 appeared as the obvious causing agent, but two years of various investigations have failed to convincingly support its direct implication. Most affected individuals have no detectable virus, no anti-SARS-CoV-2 antibodies and no symptoms of COVID-19. Analyses of skin biopsies similarly failed to unambiguously demonstrate presence of the virus or its genome. In a recent hypothesis, SARS-CoV-2 would cause the lesions before being promptly eliminated by unusually strong type I interferon responses. With others, we feel that environmental factors have not been sufficiently considered, in particular cold exposure related to unprecedented containment measures. The cause of pandemic chilblains remains a stimulating puzzle which warrants further investigation.

Published
2022

14. Cutaneous leishmaniasis due to : A therapeutic challenge.

Author

UCL - SSS/IREC/PNEU - Pôle de Pneumologie, ORL et Dermatologie, UCL - (SLuc) Centre de l'allergie, UCL - (SLuc) Service de dermatologie, UCL - SSS/IREC/CTMA - Centre de technologies moléculaires appliquées (plate-forme technologique), UCL - SSS/IREC/SLUC - Pôle St.-Luc, UCL - (SLuc) Service de médecine interne générale, Mengeot, Laura, Yombi, Jean Cyr, Baeck, Marie, UCL - SSS/IREC/PNEU - Pôle de Pneumologie, ORL et Dermatologie, UCL - (SLuc) Centre de l'allergie, UCL - (SLuc) Service de dermatologie, UCL - SSS/IREC/CTMA - Centre de technologies moléculaires appliquées (plate-forme technologique), UCL - SSS/IREC/SLUC - Pôle St.-Luc, UCL - (SLuc) Service de médecine interne générale, Mengeot, Laura, Yombi, Jean Cyr, and Baeck, Marie

Abstract

Cutaneous leishmaniasis (CL) is a chronic infectious skin disease caused by a group of protozoan parasites of the Leishmania genus. Parasites are transmitted to humans via the bite of sandflies. Leishmania aethiopica, one of the most neglected species, is the main causative agent of CL in Ethiopia, with infection characterized by reduced sensitivity to conventional drugs. Although the incidence of imported cases of CL is increasing in nonendemic areas, L aethiopica is rarely reported in travelers. We report a case of localized CL due to L aethiopica in a Belgian traveler. [...]

Published
2022

15. Een 'oedeem' van de oogleden met een onverwachte oorzaak

Author

UCL - (SLuc) Service de dermatologie, UCL - (SLuc) Centre de l'allergie, Fouarge, Alessandro, Cuvelier, Marie, Ghislain, Pierre-Dominique, Tennstedt, Dominique, UCL - (SLuc) Service de dermatologie, UCL - (SLuc) Centre de l'allergie, Fouarge, Alessandro, Cuvelier, Marie, Ghislain, Pierre-Dominique, and Tennstedt, Dominique

Abstract

Ooglidoedeem is een veelvoorkomende reden voor een consultatie bij de dermatoloog. Omdat er zoveel mogelijke oorzaken zijn, is vaak een doorgedreven onderzoek vereist, waarin de ondervraging van de patiënt altijd een cruciale rol speelt, zoals de hierna beschreven casus illustreert. Het betreft een patiënt met een bilateraal ooglidoedeem als gevolg van het gebruik van CPAP (continuous positive airway pressure), en dit in het kader van een entiteit die soms wordt miskend door dermatologen: het floppy eyelid syndrome (of syndroom van hyperlaxe oogleden).

Published
2022

16. Pyoderma gangrenosum induced by transcutaneous electrical nerve stimulation: a case report with literature review.

Author

UCL - (SLuc) Centre de prise en charge (H.I.V.), UCL - (SLuc) Département de médecine interne et services associés, UCL - SSS/IREC/PNEU - Pôle de Pneumologie, ORL et Dermatologie, UCL - (SLuc) Centre de malformations vasculaires congénitales, UCL - (SLuc) Service d'anatomie pathologique, UCL - (SLuc) Service de dermatologie, Costescu Strachinaru, Diana Isabela, De Greef, Axel, Marot, Liliane, Lerate, Valérie, Paridaens, Marie-Sophie, UCL - (SLuc) Centre de prise en charge (H.I.V.), UCL - (SLuc) Département de médecine interne et services associés, UCL - SSS/IREC/PNEU - Pôle de Pneumologie, ORL et Dermatologie, UCL - (SLuc) Centre de malformations vasculaires congénitales, UCL - (SLuc) Service d'anatomie pathologique, UCL - (SLuc) Service de dermatologie, Costescu Strachinaru, Diana Isabela, De Greef, Axel, Marot, Liliane, Lerate, Valérie, and Paridaens, Marie-Sophie

Abstract

Pyoderma gangrenosum (PG) is one of the neutrophilic dermatosis, a heterogenous group of rare inflammatory diseases affecting the skin. It is often associated with systemic diseases such as inflammatory bowel disease, rheumatoid arthritis or hematological malignancies. Classical PG is characterized by painful ulcers with violaceous, undermined border, often developing at sites of injury because of the typical pathergy phenomenon. Because of its polymorphic presentation, misdiagnosis and delayed diagnosis are common. We present a case of PG occurring after transcutaneous electrical nerve stimulation (TENS) in a young female patient with ulcerative colitis. Although electric current has previously been incriminated as a trigger for PG, to the best of our knowledge this is the first case precipitated by TENS. We report a typical case of PG occurring after an unusual stimulus and highlight the challenges that the diagnosis of this relatively rare pathology poses to the clinician.

Published
2022

17. Un 'œdème' des paupières d'origine insoupçonnée

Author

UCL - (SLuc) Service de dermatologie, UCL - (SLuc) Centre de l'allergie, Fouarge, Alessandro, Cuvelier, Marie, Ghislain, Pierre-Dominique, Tennstedt, Dominique, UCL - (SLuc) Service de dermatologie, UCL - (SLuc) Centre de l'allergie, Fouarge, Alessandro, Cuvelier, Marie, Ghislain, Pierre-Dominique, and Tennstedt, Dominique

Abstract

Les œdèmes palpébraux constituent un motif de consultation fréquent en dermatologie. La multiplicité des étiologies potentielles requiert régulièrement un bilan approfondi au sein duquel l’interrogatoire du patient demeure fondamental, comme l’illustre le cas rapporté ci-dessous. Il s’agit d’un patient ayant développé un œdème palpébral bilatéral suite à l’utilisation d’une CPAP (continuous positive airway pressure), et ce dans le cadre d’une entité méconnue des dermatologues: le floppy eyelid syndrome (ou syndrome des paupières hyperlaxes).

Published
2022

18. 'U moet er gewoon aan denken...'

Author

UCL - (SLuc) Service de dermatologie, UCL - (SLuc) Service d'anatomie pathologique, UCL - (SLuc) Centre de malformations vasculaires congénitales, Richez, Pauline, Marot, Liliane, Tromme, Isabelle, UCL - (SLuc) Service de dermatologie, UCL - (SLuc) Service d'anatomie pathologique, UCL - (SLuc) Centre de malformations vasculaires congénitales, Richez, Pauline, Marot, Liliane, and Tromme, Isabelle

Abstract

Een patiënte van 46 jaar komt naar de consultatie voor een asymptomatische rozeachtige laesie op de rechterborst. De laesie vergroot traag en is een jaar geleden verschenen.

Published
2022

19. Real-Life Effectiveness of Apremilast for the Treatment of Psoriasis in Belgium: Results From the Observational OTELO Study.

Author

UCL - (SLuc) Service de dermatologie, Ghislain, Pierre-Dominique, Lambert, Jo, Hoai, Xuãn-Lan Lam, Hillary, Tom, Roquet-Gravy, Pierre-Paul, de la Brassinne, Michel, Segaert, Siegfried, UCL - (SLuc) Service de dermatologie, Ghislain, Pierre-Dominique, Lambert, Jo, Hoai, Xuãn-Lan Lam, Hillary, Tom, Roquet-Gravy, Pierre-Paul, de la Brassinne, Michel, and Segaert, Siegfried

Abstract

Apremilast is approved for the treatment of psoriasis and psoriatic arthritis. However, data on the efficacy and safety of apremilast in clinical practice are limited. We assessed the real-world use and effectiveness of apremilast in patients with moderate to severe plaque psoriasis visiting dermatologist practices in Belgium, from the perspectives of the patient and the physician. This prospective observational study enrolled adults aged 18 years or more initiating apremilast between 6 April 2017 and 30 June 2018, per Belgian reimbursement criteria. Primary outcome was the Patient Benefit Index for Skin Diseases (PBI-S). Secondary outcomes included the Patient Global Assessment (PtGA), Dermatology Life Quality Index (DLQI), Psoriasis Area and Severity Index (PASI), and body surface area (BSA). Patients were followed up for up to 18 months. Overall, 122 enrolled patients received at least one dose of apremilast, of which 89 received treatment for more than 150 days and were included in the reference population. Treatment goals most frequently identified (at least 70% of patients) as "very important" in the PBI-S were related to physical impairments. After 6 months of apremilast treatment, 61-78% of patients reported they had achieved these goals; only 12.5% assessed their disease as severe (PtGA, 53.6% at apremilast initiation) and over half reported a DLQI score of 5 or less, indicating improved quality of life. As assessed by the physician, 68.4% and 35.1% of patients achieved at least a 50% and 75% reduction in PASI, respectively, at month 6. Apremilast was well tolerated with no new safety signals identified. Our real-world data indicate that apremilast fulfils the expectations of Belgian patients with moderate to severe psoriasis, and from the perspectives of both the patient and physician, apremilast has a positive impact on their disease. ClinicalTrials.gov Identifier NCT03097003.

Published
2022

20. 'Il suffit juste d'y penser...'

Author

UCL - (SLuc) Service de dermatologie, UCL - (SLuc) Service d'anatomie pathologique, UCL - (SLuc) Centre de malformations vasculaires congénitales, Richez, Pauline, Marot, Liliane, Tromme, Isabelle, UCL - (SLuc) Service de dermatologie, UCL - (SLuc) Service d'anatomie pathologique, UCL - (SLuc) Centre de malformations vasculaires congénitales, Richez, Pauline, Marot, Liliane, and Tromme, Isabelle

Abstract

Une patiente âgée de 46 ans se présente en consultation pour cette lésion rosée asymptomatique du sein droit. La lésion, de croissance lente, est apparue il y a un an.

Published
2022

21. Sporotrichoid distributed tuberculous panniculitis as a late complication of intravesical bacillus Calmette-Guérin (BCG) immunotherapy.

Author

UCL - (SLuc) Service de dermatologie, UCL - SSS/IREC/PNEU - Pôle de Pneumologie, ORL et Dermatologie, UCL - (SLuc) Centre de malformations vasculaires congénitales, UCL - (SLuc) Service d'anatomie pathologique, UCL - (SLuc) Centre de l'allergie, Nielens, Nina, Marot, Liliane, Baeck, Marie, UCL - (SLuc) Service de dermatologie, UCL - SSS/IREC/PNEU - Pôle de Pneumologie, ORL et Dermatologie, UCL - (SLuc) Centre de malformations vasculaires congénitales, UCL - (SLuc) Service d'anatomie pathologique, UCL - (SLuc) Centre de l'allergie, Nielens, Nina, Marot, Liliane, and Baeck, Marie

Abstract

An 82-year-old man presented with unilateral oedema of the right lower limb overlaid with multiple sporotrichoid distributed panniculitis lesions. These symptoms appeared in a context of immunodepression and were associated with significant weight loss and a deterioration in general condition. The patient's medical history, the histological findings, PCR testing, and bacterial culture led to a diagnosis of cutaneous tuberculosis due to Mycobacterium bovis. This infection occurred as a late complication of intravesical bacillus Calmette-Guérin (BCG) instillations that the patient had received as an adjunctive immunotherapy for bladder cancer. This is an unusual clinical presentation and aetiology of cutaneous tuberculosis. Indeed, the observed sporotrichoid pattern is uncommon for tuberculous mycobacteria. Moreover, the occurrence of tuberculous skin lesions after intravesical BCG instillations is extremely rare, with only a few cases described, and, to the authors' knowledge, none with such a clinical presentation. This case report suggests that a medical history of BCG immunotherapy should always be considered when assessing any infectious-type cutaneous lesions and that skin should be regarded as a possible late localization of infectious complications of this treatment.

Published
2022

22. Een circinaire spinnenbeet

Author

UCL - (SLuc) Service de dermatologie, Ahangari, Dario, UCL - (SLuc) Service de dermatologie, and Ahangari, Dario

Published
2022

26. Acquired cutis laxa from heavy chain deposition disease

Author

UCL - SSS/IREC/NEFR - Pôle de Néphrologie, UCL - (SLuc) Service de néphrologie, UCL - SSS/IREC - Institut de recherche expérimentale et clinique, UCL - (SLuc) Service d'hématologie, UCL - (SLuc) Service d'anatomie pathologique, UCL - (SLuc) Service de dermatologie, Gillion, Valentine, Vekemans, Marie-Christiane, Rinsant, Alexia, Aydin, Selda, Colmant, Caroline, Bridoux, Frank, Goffin, Eric, UCL - SSS/IREC/NEFR - Pôle de Néphrologie, UCL - (SLuc) Service de néphrologie, UCL - SSS/IREC - Institut de recherche expérimentale et clinique, UCL - (SLuc) Service d'hématologie, UCL - (SLuc) Service d'anatomie pathologique, UCL - (SLuc) Service de dermatologie, Gillion, Valentine, Vekemans, Marie-Christiane, Rinsant, Alexia, Aydin, Selda, Colmant, Caroline, Bridoux, Frank, and Goffin, Eric

Published
2022

27. Innovations 2021 en dermatologie

Author

UCL - SSS/IREC/PNEU - Pôle de Pneumologie, ORL et Dermatologie, UCL - (SLuc) Service de dermatologie, UCL - SSS/IREC - Institut de recherche expérimentale et clinique, UCL - SSS/IREC/SLUC - Pôle St.-Luc, UCL - (SLuc) Centre de l'allergie, UCL - (SLuc) Centre de malformations vasculaires congénitales, de Montjoye, Laurence, De Greef, Axel, Degraeuwe, Alexia, Harkemanne, Evelyne, Thirion, Romane, Nobile, Laura, Ghislain, Pierre-Dominique, Baeck, Marie, UCL - SSS/IREC/PNEU - Pôle de Pneumologie, ORL et Dermatologie, UCL - (SLuc) Service de dermatologie, UCL - SSS/IREC - Institut de recherche expérimentale et clinique, UCL - SSS/IREC/SLUC - Pôle St.-Luc, UCL - (SLuc) Centre de l'allergie, UCL - (SLuc) Centre de malformations vasculaires congénitales, de Montjoye, Laurence, De Greef, Axel, Degraeuwe, Alexia, Harkemanne, Evelyne, Thirion, Romane, Nobile, Laura, Ghislain, Pierre-Dominique, and Baeck, Marie

Published
2022

28. Granulomatous lesions of the skin: Do not fall into the trap.

Author

UCL - SSS/IREC/PNEU - Pôle de Pneumologie, ORL et Dermatologie, UCL - (SLuc) Service d'hématologie, UCL - (SLuc) Service de dermatologie, UCL - (SLuc) Service de médecine interne générale, Hoornaert, Ellen, Marot, Liliane, Yildiz, Halil, UCL - SSS/IREC/PNEU - Pôle de Pneumologie, ORL et Dermatologie, UCL - (SLuc) Service d'hématologie, UCL - (SLuc) Service de dermatologie, UCL - (SLuc) Service de médecine interne générale, Hoornaert, Ellen, Marot, Liliane, and Yildiz, Halil

Abstract

CASE : A 51-year-old woman was referred to investigate skin lesions present on her backside. She had no past medical history and was not taking medication. She travelled several times to China (last time in 2009) and Brazil (2015). [...]

Published
2022

29. Re-emergence of allergic contact dermatitis from chlorphenesin.

Author

UCL - SSS/IREC/PNEU - Pôle de Pneumologie, ORL et Dermatologie, UCL - (SLuc) Service de dermatologie, Herman, Anne, de Montjoye, Laurence, Baeck, Marie, UCL - SSS/IREC/PNEU - Pôle de Pneumologie, ORL et Dermatologie, UCL - (SLuc) Service de dermatologie, Herman, Anne, de Montjoye, Laurence, and Baeck, Marie

Abstract

Only a few cases of allergic contact dermatitis (ACD) from chlorphenesin have been reported and since 2015 no new cases have been published. We describe two additional cases of ACD from this preservative in cosmetics observed during late 2021. [...]

Published
2022

30. How skin and liver can lead to diagnosis

Author

UCL - (SLuc) Service de gastro-entérologie, UCL - (SLuc) Service d'anatomie pathologique, UCL - (SLuc) Service d'hématologie, UCL - (SLuc) Service de dermatologie, Vande Berg, Perrine, Vande Berg, A, Harkemanne, Evelyne, Peeters, Catherine, Havelange, Violaine, Lanthier, Nicolas, UCL - (SLuc) Service de gastro-entérologie, UCL - (SLuc) Service d'anatomie pathologique, UCL - (SLuc) Service d'hématologie, UCL - (SLuc) Service de dermatologie, Vande Berg, Perrine, Vande Berg, A, Harkemanne, Evelyne, Peeters, Catherine, Havelange, Violaine, and Lanthier, Nicolas

Published
2021

31. Dermatomyosite à anticorps anti-SAE 1/2 dans le décours d’un traitement par adalimumab : à propos d’un cas

Author

UCL - SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie, UCL - SSS/IREC/PNEU - Pôle de Pneumologie, ORL et Dermatologie, UCL - SSS/IREC/SLUC - Pôle St.-Luc, UCL - (SLuc) Service d'anatomie pathologique, UCL - (SLuc) Service de dermatologie, UCL - (SLuc) Service de médecine interne générale, UCL - (MGD) Service de médecine nucléaire, Frisson, Léa, Mahiat, Cédric, Richez, Pauline, Marot, Liliane, Colin, Henri, D'Abadie, Philippe, Lelotte, Julie, Yombi, Jean Cyr, Yildiz, Halil, UCL - SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie, UCL - SSS/IREC/PNEU - Pôle de Pneumologie, ORL et Dermatologie, UCL - SSS/IREC/SLUC - Pôle St.-Luc, UCL - (SLuc) Service d'anatomie pathologique, UCL - (SLuc) Service de dermatologie, UCL - (SLuc) Service de médecine interne générale, UCL - (MGD) Service de médecine nucléaire, Frisson, Léa, Mahiat, Cédric, Richez, Pauline, Marot, Liliane, Colin, Henri, D'Abadie, Philippe, Lelotte, Julie, Yombi, Jean Cyr, and Yildiz, Halil

Abstract

La DM est une maladie inflammatoire auto-immune touchant la peau et les muscles, dont l’étiologie reste souvent inconnue. Les DM induites par des agents biologiques comme les inhibiteurs du tumor necrosis factor alpha sont rares, décrites principalement chez des patients souffrant d’affections auto-immunes ou de néoplasies sous-jacentes. Nous rapportons le cas d’une patiente âgée de 57 ans, développant une DM à anticorps anti-SAE 1/2 suite à un traitement par adalimumab instauré dans le cadre d’une maladie de Verneuil réfractaire. Notre patiente présentait des lésions cutanées typiques (rash héliotrope, papules de Gottron), des arthralgies, des gonflements articulaires, une faiblesse musculaire proximale et une dysphagie. La biologie montrait un faible syndrome inflammatoire, une hypergammaglobulinémie polyclonale, une hypoalbuminémie, des LDH élevés, des CK, GOT et GPT normales. Les anticorps spécifiques des myosites reviennent positifs pour les anticorps anti-SAE 1/2. L’EMG et la biopsie musculaire montrent une myopathie inflammatoire. Une corticothérapie systémique a été démarrée, avec une amélioration des douleurs articulaires et de la force musculaire après 7 jours. Une récidive clinique de la pathologie survient lors de la dégression de la corticothérapie, nécessitant l’instauration d'un traitement par azathioprine avec une bonne réponse clinique et biologique., [Anti-SAE ½ antibody-associated dermatomyositis on adalimumab treatment: a case report] Dermatomyositis (DM) is an autoimmune inflammatory disorder affecting the skin and muscles, whose etiology is often unknown. While DM induced by biological agents like anti-tumor necrosis factor-alpha agents is uncommon, this disorder is mainly seen in patients with autoimmune disorders or underlying neoplasms. We report the case of a 57-year-old female patient who developed DM with anti-small ubiquitin-like modifier-1 activating enzyme (anti-SAE 1/2) antibodies following an adalimumab treatment on account of refractory hidradenitis suppurativa. Our patient presented typical cutaneous findings consisting of heliotrope rash, Gottron papule, arthralgia, joint swelling, proximal muscle weakness, and dysphagia. Laboratory studies showed mild inflammatory syndrome, polyclonal hypergammaglobulinemia, hypoalbuminemia, high LDH levels, yet normal CK, AST, and ALT levels. Myositis-specific antibody assay was found to be positive for anti-SAE 1/2 antibodies. The electromyogram (EMG) and muscle biopsy revealed inflammatory myopathy. Systemic corticosteroid therapy was initiated. As a result, the patient’s joint pain and muscle strength both improved following 7 days of treatment. A clinical recurrence of the pathology occurred during the gradual regression of corticosteroid therapy, requiring the initiation of azathioprine with both good clinical and biological responses.

Published
2021

32. Sensitization to isobornyl acrylate in a tertiary Belgian hospital.

Author

UCL - (SLuc) Service de dermatologie, UCL - SSS/IREC/PNEU - Pôle de Pneumologie, ORL et Dermatologie, UCL - (SLuc) Centre de l'allergie, Herman, Anne, Baeck, Marie, UCL - (SLuc) Service de dermatologie, UCL - SSS/IREC/PNEU - Pôle de Pneumologie, ORL et Dermatologie, UCL - (SLuc) Centre de l'allergie, Herman, Anne, and Baeck, Marie

Abstract

No abstract available

Published
2021

33. A case report of cutaneous leishmaniasis: a misleading clinical presentation.

Author

UCL - (SLuc) Service de dermatologie, UCL - (SLuc) Service d'anatomie pathologique, UCL - SSS/IREC/SLUC - Pôle St.-Luc, UCL - (SLuc) Centre de prise en charge (H.I.V.), UCL - SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie, UCL - (SLuc) Centre de l'allergie, UCL - SSS/IREC/PNEU - Pôle de Pneumologie, ORL et Dermatologie, UCL - (SLuc) Centre de malformations vasculaires congénitales, UCL - (SLuc) Service de médecine interne générale, UCL - (SLuc) Service de médecine nucléaire, Vanlier, Corentine, Marot, Liliane, Laranaga, Eva, D'Abadie, Philippe, Yombi, Jean Cyr, Yildiz, Halil, Baeck, Marie, UCL - (SLuc) Service de dermatologie, UCL - (SLuc) Service d'anatomie pathologique, UCL - SSS/IREC/SLUC - Pôle St.-Luc, UCL - (SLuc) Centre de prise en charge (H.I.V.), UCL - SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie, UCL - (SLuc) Centre de l'allergie, UCL - SSS/IREC/PNEU - Pôle de Pneumologie, ORL et Dermatologie, UCL - (SLuc) Centre de malformations vasculaires congénitales, UCL - (SLuc) Service de médecine interne générale, UCL - (SLuc) Service de médecine nucléaire, Vanlier, Corentine, Marot, Liliane, Laranaga, Eva, D'Abadie, Philippe, Yombi, Jean Cyr, Yildiz, Halil, and Baeck, Marie

Abstract

BACKGROUND: The diagnosis of cutaneous leishmaniasis (CL) is often difficult because of the diversity of clinical presentations, its often-misleading appearance and the very long incubation period (time between the endemic stay and the onset of skin lesions). CASE: We report the case of an otherwise healthy 67-year-old man who presented with inflammatory skin lesions on the scalp and face for the past 7 years. The lesions were first mistaken as cutaneous sarcoidosis, mycobacterial infection, and cutaneous lymphoma. Finally, the diagnosis was made by RT-PCR analysis on a punch-biopsy specimen, which was positive for Leishmania infantum. DISCUSSION AND CONCLUSION: To date, the choice of treatment for complex cutaneous leishmaniases is based on the Leishmania species. Our patient successfully responded to liposomal amphotericin B.

Published
2021

34. Improvement in Hidradenitis Suppurativa and quality of life in patients treated with adalimumab: Real-world results from the HARMONY Study.

Author

UCL - SSS/IREC/SLUC - Pôle St.-Luc, UCL - (SLuc) Service de dermatologie, Hafner, A, Ghislain, P D, Kovács, R, Batchelor, R, Katoulis, A C, Kirby, B, Banayan, H, Schonbrun, M, UCL - SSS/IREC/SLUC - Pôle St.-Luc, UCL - (SLuc) Service de dermatologie, Hafner, A, Ghislain, P D, Kovács, R, Batchelor, R, Katoulis, A C, Kirby, B, Banayan, H, and Schonbrun, M

Abstract

Hidradenitis suppurativa (HS), a chronic, recurrent, debilitating skin disease, is characterized by painful, inflammatory, subcutaneous lesions of the axilla, inguinal and anogenital regions. Overall prevalence of HS is ˜1%, and the impact of disease on patient quality of life (QoL) and healthcare resource utilization (HRU) is high. To estimate the real-world effectiveness of adalimumab (Humira®) treatment in patients with moderate-to-severe HS on disease severity, pain, QoL, work productivity and HRU. HARMONY (Effectiveness of Adalimumab in Moderate to Severe HidrAdenitis SuppuRativa Patients - a Multi-cOuNtry studY in Real Life Setting) is a multicentre, postmarketing observational study in adult patients with moderate-to-severe HS. Disease severity and QoL parameters were evaluated using validated measures at 12-week intervals over 52 weeks of treatment. The primary endpoint was the proportion of patients achieving a Hidradenitis Suppurativa Clinical Response (HiSCR: ≥50% reduction in abscess and inflammatory nodule count, with no increase in abscess and draining fistula counts relative to baseline) at 12 weeks. Secondary endpoints were HiSCR at 24, 36 and 52 weeks and changes in QoL parameters and work productivity assessments. Analyses were conducted using as-observed data. The proportion of patients reaching the primary HiSCR endpoint was 70.2% (n = 132/188 enrolled) and remained ≥70% until study completion. There were statistically significant (P < 0.0001) reductions in worst and average skin pain. All of the QoL measures evaluated improved significantly (P < 0.0001) by 12 weeks of adalimumab treatment, as did work productivity assessments (P < 0.05), and there was a ˜50% decrease in HRU between baseline and week 52. Adalimumab was well tolerated. In this real-world setting, adalimumab treatment of moderate-to-severe HS resulted in decreased disease severity and improvements in QoL and productivity. Response to adalimumab was rapid (within 12 weeks) and susta

Published
2021

35. Position statement: The need for EU legislation to require disclosure and labelling of the composition of medical devices.

Author

UCL - SSS/IREC/SLUC - Pôle St.-Luc, UCL - (SLuc) Service de dermatologie, Herman, A, Uter, W, Rustemeyer, T, Matura, M, Aalto-Korte, K, Duus Johansen, J, Gonçalo, M, White, I R, Balato, A, Giménez Arnau, A M, Brockow, K, Mortz, C G, Mahler, V, Goossens, A, ESCD, EECDRG, EADV Contact Dermatitis Task Force, EAACI, UCL - SSS/IREC/SLUC - Pôle St.-Luc, UCL - (SLuc) Service de dermatologie, Herman, A, Uter, W, Rustemeyer, T, Matura, M, Aalto-Korte, K, Duus Johansen, J, Gonçalo, M, White, I R, Balato, A, Giménez Arnau, A M, Brockow, K, Mortz, C G, Mahler, V, Goossens, A, and ESCD, EECDRG, EADV Contact Dermatitis Task Force, EAACI

Abstract

In recent years, skin reactions secondary to the use of medical devices (MD), such as allergic contact dermatitis have increasingly been observed (e.g. to continuous blood sugar monitoring systems, insulin pumps, wound dressings, medical gloves, etc.): this is regarded as a developing epidemic. Lack of labelling of the composition of MD, as well as frequent lack of cooperation of manufacturers to disclose this relevant information, even when contacted by the clinician for the individual case of an established adverse reaction, significantly impede patient care. To advocate for full ingredient labelling in the implementation of EU regulation for MD. This position paper reviews the scientific literature, the current regulatory framework adopted for MD to date, and the likely impact, including some costs data in case of the absence of such labelling. Efforts made by several scientific teams, who are trying to identify the culprit of such adverse effects, either via asking for cooperation from companies, or using costly chemical analyses of MD, can only partly, and with considerable delay, compensate for the absence of meaningful information on the composition of MD; hence, patient management is compromised. Indeed, without knowing the chemical substances present, physicians are unable to inform patients about which substances they should avoid, and which alternative MD may be suitable/tolerated. There is an urgent need for full and accurate labelling of the chemical composition of MD in contact with the human body.

Published
2021

36. Effectiveness and tolerability of guselkumab in patients with psoriasis: A longitudinal Belgian retrospective multicenter study.

Author

UCL - SSS/IREC/SLUC - Pôle St.-Luc, UCL - (SLuc) Service de dermatologie, Ghislain, Pierre-Dominique, Failla, Valérie, Lambert, Jo, Soenen, Rani, Grine, Lynda, Tannous, Julio, Guiot, Françoise, Willaert, Fabienne, Fierens, Hugues, Vandaele, Mark, Boonen, Hugo, Saerens, Julie, Meuleman, Véronique, Stockman, Annelies, Belpaire, Arno, Swimberghe, Sandra, Temmerman, Linda, Dekeyser, Sam, Lambert, Jean-Michel, de Schaetzen, Virginie, de la Brassinne, Michel, Benhadou, Farida, UCL - SSS/IREC/SLUC - Pôle St.-Luc, UCL - (SLuc) Service de dermatologie, Ghislain, Pierre-Dominique, Failla, Valérie, Lambert, Jo, Soenen, Rani, Grine, Lynda, Tannous, Julio, Guiot, Françoise, Willaert, Fabienne, Fierens, Hugues, Vandaele, Mark, Boonen, Hugo, Saerens, Julie, Meuleman, Véronique, Stockman, Annelies, Belpaire, Arno, Swimberghe, Sandra, Temmerman, Linda, Dekeyser, Sam, Lambert, Jean-Michel, de Schaetzen, Virginie, de la Brassinne, Michel, and Benhadou, Farida

Abstract

No abstract available

Published
2021

37. COVID toes: where do we stand with the current evidence?

Author

UCL - (SLuc) Service de dermatologie, UCL - SSS/IREC/PNEU - Pôle de Pneumologie, ORL et Dermatologie, Baeck, Marie, Herman, Anne, UCL - (SLuc) Service de dermatologie, UCL - SSS/IREC/PNEU - Pôle de Pneumologie, ORL et Dermatologie, Baeck, Marie, and Herman, Anne

Abstract

BACKGROUND: Numerous of cases of chilblains have been observed, mainly in young subjects with no or mild symptoms compatible with COVID-19. The pathophysiology of these lesions is still widely debated and an association with SARS-CoV-2 infection remains unconfirmed. OBJECTIVES: This paper focus on the unresolved issues about these COVID toes and in particular whether or not they are associated with COVID-19. ARGUMENTS: The temporal link between the outbreak of chilblains and the COVID-19 pandemic is a first suggests a link between the two events. Positive anti-SARS-CoV/SARS-CoV-2 immunostaining on skin biopsy of chilblains seem to confirm the presence of the virus in the lesions, but lack specificity and must be interpreted with caution. Conversely, RT-PCR and anti-SARS-CoV-2 serology were negative in the majority of patients with chilblains. Therefore, SARS-CoV-2 infection can be excluded, with relative certainty, even after accounting for possible lower immunization in mild/asymptomatic patients and for some differences in sensitivity/specificity between the tests used. Some authors hypothesize that chilblains could be the cutaneous expression of a strong type I interferon (IFN-I) response. High production of IFN-I is suggested to be associated with early viral control and may suppress antibody response. However, the absence of other cutaneous or extracutaneous symptoms as observed in other interferonopathies raises unanswered questions. To date, a direct link between chilblains and COVID-19 still seems impossible to confirm. A more indirect association due to lifestyle changes induced by lockdown is a possible explanation. Improvement of chilblains when protective measures were adopted and after lifting of lockdown, support this hypothesis. CONCLUSION: Conflicting current evidence highlights the need for systematic and repeated testing of larger numbers of patients and the need for valid follow-up data that take into consideration epidemic curves and evolution of

Published
2021

38. Medial unicomportemental knee arthroplasty

Author

UCL - SSS/IREC/CARS - Computer Assisted Robotic Surgery, UCL - (SLuc) Service de dermatologie, Thienpont, Emmanuel, Partial Knee Replacement : Online Symposium, UCL - SSS/IREC/CARS - Computer Assisted Robotic Surgery, UCL - (SLuc) Service de dermatologie, Thienpont, Emmanuel, and Partial Knee Replacement : Online Symposium

Published
2021

39. Chilblains and COVID-19: further evidence against a causal association.

Author

UCL - SSS/IREC/PNEU - Pôle de Pneumologie, ORL et Dermatologie, UCL - (SLuc) Service de dermatologie, UCL - (SLuc) Centre de l'allergie, Baeck, Marie, Peeters, Caroline, Herman, Anne, UCL - SSS/IREC/PNEU - Pôle de Pneumologie, ORL et Dermatologie, UCL - (SLuc) Service de dermatologie, UCL - (SLuc) Centre de l'allergie, Baeck, Marie, Peeters, Caroline, and Herman, Anne

Abstract

Editor, Acro-ischaemic lesions have been observed both in adults withsevere forms of COVID-19 and in younger patients with no ormild symptoms of COVID-19 [...]

Published
2021

40. Skin lesions of face and scalp - Classification by a market-approved convolutional neural network in comparison with 64 dermatologists.

Author

UCL - SSS/IRSS - Institut de recherche santé et société, UCL - (SLuc) Service de dermatologie, Haenssle, Holger Andreas, Winkler, Julia Katharina, Fink, Christine, Toberer, Ferdinand, Enk, Alexander, Stolz, Wilhelm, Deinlein, Teresa, Hofmann-Wellenhof, Rainer, Kittler, Harald, Tschandl, Philipp, Rosendahl, Cliff, Lallas, Aimilios, Blum, Andreas, Abassi, Mohamed Souhayel, Thomas, Luc, Tromme, Isabelle, Rosenberger, Albert, Reader study level-I and level-II Groups Christina Alt, UCL - SSS/IRSS - Institut de recherche santé et société, UCL - (SLuc) Service de dermatologie, Haenssle, Holger Andreas, Winkler, Julia Katharina, Fink, Christine, Toberer, Ferdinand, Enk, Alexander, Stolz, Wilhelm, Deinlein, Teresa, Hofmann-Wellenhof, Rainer, Kittler, Harald, Tschandl, Philipp, Rosendahl, Cliff, Lallas, Aimilios, Blum, Andreas, Abassi, Mohamed Souhayel, Thomas, Luc, Tromme, Isabelle, Rosenberger, Albert, and Reader study level-I and level-II Groups Christina Alt

Abstract

BACKGROUND: The clinical differentiation of face and scalp lesions (FSLs) is challenging even for trained dermatologists. Studies comparing the diagnostic performance of a convolutional neural network (CNN) with dermatologists in FSL are lacking. METHODS: A market-approved CNN (Moleanalyzer-Pro, FotoFinder Systems) was used for binary classifications of 100 dermoscopic images of FSL. The same lesions were used in a two-level reader study including 64 dermatologists (level I: dermoscopy only; level II: dermoscopy, clinical close-up images, textual information). Primary endpoints were the CNN's sensitivity and specificity in comparison with the dermatologists' management decisions in level II. Generalizability of the CNN results was tested by using four additional external data sets. RESULTS: The CNN's sensitivity, specificity and ROC AUC were 96.2% [87.0%-98.9%], 68.8% [54.7%-80.1%] and 0.929 [0.880-0.978], respectively. In level II, the dermatologists' management decisions showed a mean sensitivity of 84.2% [82.2%-86.2%] and specificity of 69.4% [66.0%-72.8%]. When fixing the CNN's specificity at the dermatologists' mean specificity (69.4%), the CNN's sensitivity (96.2% [87.0%-98.9%]) was significantly higher than that of dermatologists (84.2% [82.2%-86.2%]; p < 0.001). Dermatologists of all training levels were outperformed by the CNN (all p < 0.001). In confirmation, the CNN's accuracy (83.0%) was significantly higher than dermatologists' accuracies in level II management decisions (all p < 0.001). The CNN's performance was largely confirmed in three additional external data sets but particularly showed a reduced specificity in one Australian data set including FSL on severely sun-damaged skin. CONCLUSIONS: When applied as an assistant system, the CNN's higher sensitivity at an equivalent specificity may result in an improved early detection of face and scalp skin cancers.

Published
2021

41. Curieux nodule du bras

Author

UCL - SSS/IRSS - Institut de recherche santé et société, UCL - (SLuc) Service de dermatologie, Richez, Pauline, Tromme, Isabelle, UCL - SSS/IRSS - Institut de recherche santé et société, UCL - (SLuc) Service de dermatologie, Richez, Pauline, and Tromme, Isabelle

Published
2021

42. Beleid van oculaire manifestaties bij atopische dermatitis en dupilumab-geassocieerde conjunctivitis

Author

UCL - SSS/IREC/PNEU - Pôle de Pneumologie, ORL et Dermatologie, UCL - (SLuc) Service de dermatologie, Gutermuth, Jan, Delbeke, Heleen, Hillary, Tom, Kreps, Elke O., Leysen, Julie, Roquet-Gravy, Pierre-Paul, Tennstedt, Dominique, Valyi, Zsuzsanna, UCL - SSS/IREC/PNEU - Pôle de Pneumologie, ORL et Dermatologie, UCL - (SLuc) Service de dermatologie, Gutermuth, Jan, Delbeke, Heleen, Hillary, Tom, Kreps, Elke O., Leysen, Julie, Roquet-Gravy, Pierre-Paul, Tennstedt, Dominique, and Valyi, Zsuzsanna

Published
2021

43. Prise en charge des manifestations oculaires dans la dermatite atopique et la conjonctivite associée au dupilumab

Author

UCL - SSS/IREC/PNEU - Pôle de Pneumologie, ORL et Dermatologie, UCL - (SLuc) Service de dermatologie, Gutermuth, Jan, Delbeke, Heleen, Hillary, Tom, Kreps, Elke O., Leysen, Julie, Roquet-Gravy Pierre-Paul, Tennstedt, Dominique, Valyi, Zsuzsanna, UCL - SSS/IREC/PNEU - Pôle de Pneumologie, ORL et Dermatologie, UCL - (SLuc) Service de dermatologie, Gutermuth, Jan, Delbeke, Heleen, Hillary, Tom, Kreps, Elke O., Leysen, Julie, Roquet-Gravy Pierre-Paul, Tennstedt, Dominique, and Valyi, Zsuzsanna

Published
2021

47. Vreemde knobbel op de arm

Author

UCL - SSS/IRSS - Institut de recherche santé et société, UCL - (SLuc) Service de dermatologie, Richez, Pauline, Tromme, Isabelle, UCL - SSS/IRSS - Institut de recherche santé et société, UCL - (SLuc) Service de dermatologie, Richez, Pauline, and Tromme, Isabelle

Published
2021

50. 'Blue-black' rule

Author

UCL - SSS/IRSS - Institut de recherche santé et société, UCL - (SLuc) Service de dermatologie, Tromme, Isabelle, Richez, Pauline, UCL - SSS/IRSS - Institut de recherche santé et société, UCL - (SLuc) Service de dermatologie, Tromme, Isabelle, and Richez, Pauline

Published
2021

Catalog

Books, media, physical & digital resources
See catalog results